These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17947473)

  • 21. Frequent CpG island methylation in serrated adenomas of the colorectum.
    Park SJ; Rashid A; Lee JH; Kim SG; Hamilton SR; Wu TT
    Am J Pathol; 2003 Mar; 162(3):815-22. PubMed ID: 12598316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of viral DNA sequences in sporadic colorectal cancers in relation to CpG island methylation and methylator phenotype.
    Karpinski P; Myszka A; Ramsey D; Kielan W; Sasiadek MM
    Tumour Biol; 2011 Aug; 32(4):653-9. PubMed ID: 21625944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotype of microsatellite-stable colorectal carcinomas with CpG island methylation.
    Chirieac LR; Shen L; Catalano PJ; Issa JP; Hamilton SR
    Am J Surg Pathol; 2005 Apr; 29(4):429-36. PubMed ID: 15767794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal cancer "methylator phenotype": fact or artifact?
    Anacleto C; Leopoldino AM; Rossi B; Soares FA; Lopes A; Rocha JC; Caballero O; Camargo AA; Simpson AJ; Pena SD
    Neoplasia; 2005 Apr; 7(4):331-5. PubMed ID: 15967110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study.
    O'Dwyer PJ; Manola J; Valone FH; Ryan LM; Hines JD; Wadler S; Haller DG; Arbuck SG; Weiner LM; Mayer RJ; Benson AB
    J Clin Oncol; 2001 May; 19(9):2413-21. PubMed ID: 11331320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
    Vedeld HM; Merok M; Jeanmougin M; Danielsen SA; Honne H; Presthus GK; Svindland A; Sjo OH; Hektoen M; Eknaes M; Nesbakken A; Lothe RA; Lind GE
    Int J Cancer; 2017 Sep; 141(5):967-976. PubMed ID: 28542846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
    Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
    Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CpG island methylation in colorectal adenomas.
    Rashid A; Shen L; Morris JS; Issa JP; Hamilton SR
    Am J Pathol; 2001 Sep; 159(3):1129-35. PubMed ID: 11549606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype.
    O'Brien MJ; Yang S; Clebanoff JL; Mulcahy E; Farraye FA; Amorosino M; Swan N
    Am J Surg Pathol; 2004 Apr; 28(4):423-34. PubMed ID: 15087661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased frequency of CpG island methylator phenotype and CDH1 methylation in a gastric cancer high-risk region of china.
    Zhang KL; Sun Y; Li Y; Liu M; Qu B; Cui SH; Kong QY; Chen XY; Li H; Liu J
    Transl Oncol; 2008 Mar; 1(1):28-35. PubMed ID: 18607505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between CpG island methylator phenotype and genetic instability in sporadic colorectal cancer].
    Cai GX; Xu Y; Cai SJ; Shi YQ; Lian P; Peng JJ; Guan ZQ; Du X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov; 10(6):555-60. PubMed ID: 18000779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer.
    Worthley DL; Whitehall VL; Buttenshaw RL; Irahara N; Greco SA; Ramsnes I; Mallitt KA; Le Leu RK; Winter J; Hu Y; Ogino S; Young GP; Leggett BA
    Oncogene; 2010 Mar; 29(11):1653-62. PubMed ID: 19966864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component.
    Kakar S; Deng G; Cun L; Sahai V; Kim YS
    Hum Pathol; 2008 Jan; 39(1):30-6. PubMed ID: 17950780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
    Konishi K; Shen L; Wang S; Meltzer SJ; Harpaz N; Issa JP
    Gastroenterology; 2007 Apr; 132(4):1254-60. PubMed ID: 17408633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.
    Slattery ML; Curtin K; Sweeney C; Levin TR; Potter J; Wolff RK; Albertsen H; Samowitz WS
    Int J Cancer; 2007 Feb; 120(3):656-63. PubMed ID: 17096326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG island methylator phenotype predicts progression of malignant melanoma.
    Tanemura A; Terando AM; Sim MS; van Hoesel AQ; de Maat MF; Morton DL; Hoon DS
    Clin Cancer Res; 2009 Mar; 15(5):1801-7. PubMed ID: 19223509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.
    Murcia O; Juárez M; Rodríguez-Soler M; Hernández-Illán E; Giner-Calabuig M; Alustiza M; Egoavil C; Castillejo A; Alenda C; Barberá V; Mangas-Sanjuan C; Yuste A; Bujanda L; Clofent J; Andreu M; Castells A; Llor X; Zapater P; Jover R
    PLoS One; 2018; 13(9):e0203051. PubMed ID: 30188916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy.
    Gallois C; Taieb J; Le Corre D; Le Malicot K; Tabernero J; Mulot C; Seitz JF; Aparicio T; Folprecht G; Lepage C; Mini E; Van Laethem JL; Emile JF; Laurent-Puig P;
    Clin Cancer Res; 2018 Oct; 24(19):4745-4753. PubMed ID: 29921730
    [No Abstract]   [Full Text] [Related]  

  • 40. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.